Abstract
Thousands of coronary bypass operations are performed in Canada each year. Some result in longer life or improved quality of life by reducing angina, but others do not. Where the potential benefit is unknown, physicians must consider the patient's work, home life, and personality. Clinical intuition is still needed to determine which patients will benefit.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Califf R. M., Pryor D. B., Greenfield J. C., Jr Beyond randomized clinical trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation. 1986 Dec;74(6):1191–1194. doi: 10.1161/01.cir.74.6.1191. [DOI] [PubMed] [Google Scholar]
- Neu H. C. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases. Am J Med. 1985 Nov 29;79(5B):2–12. doi: 10.1016/0002-9343(85)90123-8. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Steele L. C., Brooks D. L., Luman J. I., Wilson R. W., McLarty J. W. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Jun;27(6):912–915. doi: 10.1128/aac.27.6.912. [DOI] [PMC free article] [PubMed] [Google Scholar]